This inventor holds 7 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignees: Norchip A/s, Nye Colifast as. Active years: 2004-2013.
Location History:
- Klokkarstua, NO (2004 - 2013)
- Klokkarstua, NL (2013)
Company Filing History:
Years Active: 2004-2013
Title: Frank Karlsen: Innovator in Medical Technology
Introduction
Frank Karlsen is a notable inventor based in Klokkarstua, Norway. He has made significant contributions to the field of medical technology, particularly in the detection of diseases and the extraction of nucleic acids. With a total of 7 patents to his name, Karlsen's work has the potential to impact healthcare positively.
Latest Patents
Karlsen's latest patents include a method for detecting human papillomavirus (HPV) mRNA. This innovative in vitro method screens human female subjects to assess their risk of developing cervical carcinoma. The method involves screening for the expression of mRNA transcripts from the E6 and optionally the L1 gene of HPV. Subjects who test positive for L1 and/or E6 mRNA are identified as being at risk of developing cervical carcinoma. Additionally, he has developed a device for carrying out cell lysis and nucleic acid extraction. This integrated lab-on-a-chip device streamlines the nucleic acid extraction process on fluid samples containing cells and/or particles.
Career Highlights
Throughout his career, Frank Karlsen has worked with several companies, including Norchip AS and Nye Colifast AS. His experience in these organizations has contributed to his expertise in medical technology and innovation.
Collaborations
Karlsen has collaborated with notable individuals in his field, including Klaus Stefan Drese and Olaf Sorensen. These collaborations have likely enhanced his research and development efforts.
Conclusion
Frank Karlsen is a distinguished inventor whose work in medical technology continues to advance the field. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.